TFEB-Amplified Renal Cell Carcinoma: Integrating Histopathologic and Molecular Diagnostics with Therapeutic Implications
{{output}}
TFEB-amplified renal cell carcinoma (RCC) represents a newly described and rare aggressive molecular subtype of RCC that is characterized by TFEB gene amplification (6p21.1). These tumors are characterized by heterogeneous morphology (papillary, tubulocystic, ... ...
